Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Prof. dr. Gisela Terwindt streeft naar meer vrouwspecifiek hersenonderzoek
nov 2020 | Hoofdpijn